충돌증후군 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 근골격계 질환 종류별, 진단 및 영상 진단 기술별, 치료법별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Impingement Syndrome Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type of Musculoskeletal Disorder, By Diagnosis and Imaging Techniques, By Treatment Modalities, By End User, By Region and Competition, 2020-2030F
상품코드:1667998
리서치사:TechSci Research
발행일:2025년 02월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
충돌증후군 세계 시장은 2024년 81억 2,000만 달러로 평가되며, 예측 기간 동안 7.43%의 CAGR로 2030년에는 125억 1,000만 달러에 달할 것으로 예상됩니다.
충돌증후군은 어깨 충돌증이라고도 하며, 전 세계적으로 수백만 명이 앓고 있는 흔한 근골격계 질환입니다. 어깨 힘줄이 눌리거나 자극을 받아 발생하며 통증, 운동 범위 감소, 기능적 제한을 유발합니다. 이 질환의 진단, 치료, 치료를 포함한 전 세계 충돌증후군 시장은 최근 몇 년 동안 괄목할 만한 성장세를 보이고 있습니다. 충돌증후군 시장에는 엑스레이, MRI 스캔, 신체 검사와 같은 진단 도구와 물리치료, 코르티코스테로이드 주사, 최소침습 수술과 같은 비수술적 및 수술적 치료 등 다양한 제품 및 서비스가 포함됩니다. 이 시장의 성장을 촉진하는 주요 요인으로는 충돌증후군의 유병률 증가, 근골격계 질환에 대한 인식 증가, 의료 기술의 발전 등을 들 수 있습니다. 충돌증후군의 유병률은 전 세계적으로 증가 추세에 있으며, 그 주요 원인은 인구 고령화와 나쁜 자세, 앉아서 생활하는 습관 등 생활습관 요인에 기인합니다. 어깨 통증과 불편함으로 병원을 찾는 사람들이 늘어남에 따라 진단 및 치료 옵션에 대한 수요가 증가하고 있습니다. 어깨 통증과 불편함이 증가함에 따라 진단 및 치료 옵션에 대한 수요도 증가하고 있습니다. 관절경과 같은 수술은 기존 개복 수술에 비해 회복이 빠르고 수술 후 통증이 덜하기 때문에 수요가 증가하고 있습니다. 혈소판풍부혈장(PRP) 및 줄기세포 치료와 같은 재생 치료는 충돌증후군의 잠재적 치료법으로 떠오르고 있습니다. 이러한 치료는 신체의 자연 치유 과정을 자극하는 것을 목표로 하며, 덜 침습적이고 더 효과적인 치료법을 제공할 수 있으며, COVID-19 팬데믹은 의료 분야에서 원격의료 및 원격 모니터링의 채택을 가속화했습니다. 이러한 기술을 통해 환자들은 충돌증후군의 진단 및 후속 치료에 더 쉽게 접근할 수 있게 되어 편리하고 효율적인 의료 솔루션을 제공할 수 있게 되었습니다. 충돌증후군 세계 시장은 인지도 향상, 의료 기술 발전, 질환의 유병률 증가에 힘입어 성장세를 보이고 있습니다. 상환 문제 및 경쟁과 같은 도전과제가 존재하지만, 맞춤형 의료, 신흥 시장, 공동 연구, 디지털 건강 솔루션과 같은 비즈니스 기회는 시장에 유망한 미래를 가져다 줄 것입니다. 연구와 혁신이 진행됨에 따라, 충돌증후군 시장은 전 세계 환자들에게 더 나은 치료와 결과를 제공할 수 있는 잠재력을 가지고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
81억 2,000만 달러
시장 규모 : 2030년
125억 1,000만 달러
CAGR : 2025-2030년
7.43%
급성장 부문
의약품
최대 시장
북미
시장 촉진요인
충돌증후군의 유병률 증가로 인한 충돌증후군 세계 시장 확대 전망
주요 시장 과제
제한된 인지도와 오진
주요 시장 동향
기술 발전
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 충돌증후군 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
근골격계 질환 종류별(골관절염, 류마티스 관절염, 골다공증, 허리 및 목 통증, 어깨 충돌 증후군, 무릎 통증과 장애, 고관절 통증과 장애, 외상과 골절, 스포츠 부상, 기타)
진단 및 영상 진단 기술별(X선, 자기공명영상(MRI), 컴퓨터 단층촬영(CT) 스캔, 초음파, 관절경 검사, 기타)
치료법별(약물요법과 외과적 개입)
최종사용자별(병원·진료소, 외래 진료 센터, 기타)
지역별
기업별(2024년)
시장 맵
제6장 북미의 충돌증후군 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
캐나다
멕시코
제7장 유럽의 충돌증후군 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
영국
이탈리아
프랑스
스페인
제8장 아시아태평양의 충돌증후군 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
인도
일본
한국
호주
제9장 남미의 충돌증후군 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 충돌증후군 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병(있는 경우)
제품 발매(있는 경우)
최근 동향
제13장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제14장 경쟁 구도
Bioventus LLC
Orthofix Medical Inc.
Breg, Inc.
ConMed Corporation
Ossur hf.
Arthrex, Inc.
Globus Medical, Inc.
NuVasive, Inc.
Stryker Corporation
Medtronic plc
제15장 전략적 제안
ksm
영문 목차
영문목차
Global Impingement Syndrome Market was valued at USD 8.12 Billion in 2024 and is expected to reach USD 12.51 Billion by 2030 with a CAGR of 7.43% during the forecast period. Impingement syndrome, also known as shoulder impingement, is a common musculoskeletal condition that affects millions of people worldwide. It occurs when the tendons in the shoulder become compressed or irritated, leading to pain, reduced range of motion, and functional limitations. The global impingement syndrome market, which includes diagnostics, treatments, and therapies for this condition, has witnessed significant growth in recent years. The impingement syndrome market comprises a range of products and services, including diagnostic tools such as X-rays, MRI scans, and physical examinations, as well as non-surgical and surgical treatments like physical therapy, corticosteroid injections, and minimally invasive procedures. Key factors driving the growth of this market include the rising incidence of impingement syndrome, increasing awareness about musculoskeletal disorders, and advancements in medical technology. The prevalence of impingement syndrome is on the rise globally, primarily due to aging populations and lifestyle factors such as poor posture and sedentary behavior. As more individuals seek medical attention for shoulder pain and discomfort, the demand for diagnosis and treatment options is growing. Minimally invasive surgical techniques have gained popularity in the treatment of impingement syndrome. Procedures like arthroscopy offer quicker recovery times and reduced post-operative pain compared to traditional open surgery, driving demand for these techniques. Regenerative therapies such as platelet-rich plasma (PRP) and stem cell therapy are emerging as potential treatments for impingement syndrome. These therapies aim to stimulate the body's natural healing processes, offering a less invasive and potentially more effective treatment option. The COVID-19 pandemic accelerated the adoption of telemedicine and remote monitoring in healthcare. These technologies have made it easier for patients to access consultations and follow-up care for impingement syndrome, providing a convenient and efficient healthcare solution. The global impingement syndrome market is poised for growth, driven by increasing awareness, advancements in medical technology, and a rising prevalence of the condition. While challenges such as reimbursement issues and competition exist, opportunities in personalized medicine, emerging markets, collaborative research, and digital health solutions offer a promising future for the market. As research and innovation continue to advance, the impingement syndrome market has the potential to provide better care and outcomes for patients worldwide.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 8.12 Billion
Market Size 2030
USD 12.51 Billion
CAGR 2025-2030
7.43%
Fastest Growing Segment
Medications
Largest Market
North America
Key Market Drivers
Rising Prevalence of Impingement Syndrome is Driving the Global Impingement Syndrome Market
Impingement syndrome, also known as shoulder impingement, is a common orthopedic condition that affects millions of people worldwide. This condition occurs when the tendons or bursa in the shoulder become compressed or irritated, leading to pain, limited range of motion, and decreased quality of life. In recent years, the global Impingement Syndrome market has witnessed significant growth due to the rising prevalence of this condition and the increasing demand for effective treatment options.
Impingement syndrome primarily affects the shoulder joint, making it a common orthopedic ailment. It is often seen in individuals who engage in repetitive overhead activities, such as athletes, manual laborers, and individuals who perform tasks that require constant shoulder use. The aging population also plays a significant role in the increasing prevalence of this condition, as degenerative changes in the shoulder joint can make individuals more susceptible to impingement. Moreover, lifestyle factors such as poor posture, sedentary habits, and obesity contribute to the development of Impingement Syndrome. As these risk factors become more prevalent in modern society, the number of people diagnosed with shoulder impingement continues to rise. According to a study, "Shoulder impingement syndrome: impingement view and arthrography study based on 100 cases", aprospective evaluation was conducted to assess the combination of shoulder impingement views and arthrography in patients with chronic shoulder pain. A total of 523 patients with chronic shoulder pain underwent X-rays using both conventional and impingement views. Among them, 100 patients (mean age 62) were found to have subacromial bony spurs on the impingement view and underwent arthrography. These patients were divided into two groups based on the degree of spur formation, specifically whether the spur size exceeded half the acromial width, measured from the outer margin to the acromioclavicular joint. Of the 100 subacromial spurs identified on the impingement view, only 18 were visible on the conventional view, as assessed by an independent radiologist. Arthrography revealed 35 cases of rotator cuff tears, and the size of the bony spur was significantly associated with the occurrence of rotator cuff tears (P < 0.02).
Key Market Challenges
Limited Awareness and Misdiagnosis
One of the most significant obstacles in the impingement syndrome market is the limited awareness of the condition, both among the general public and healthcare professionals. Many individuals experiencing shoulder or hip pain may not immediately recognize the symptoms as indicative of impingement syndrome, often attributing the discomfort to general wear and tear, muscle strain, or other non-specific causes. This lack of awareness can lead to delayed diagnoses and subsequent delays in appropriate treatment, which can worsen the condition and increase the complexity of treatment. Additionally, healthcare providers may overlook the symptoms as they may present similarly to other musculoskeletal disorders, such as tendonitis or rotator cuff injuries, further complicating the diagnosis. The absence of early intervention can lead to chronic pain, impaired mobility, and a greater risk of developing secondary complications, ultimately contributing to higher healthcare costs due to prolonged treatment and rehabilitation needs. Increased education and awareness, particularly among general practitioners and physical therapists, are essential for timely identification and intervention.
Key Market Trends
Technological Advancements
Technological advancements have revolutionized healthcare across the globe, and the field of orthopedics is no exception. One area where these advancements are making a significant impact is in the treatment and management of Impingement Syndrome. This condition, characterized by pain and restricted movement in the shoulder, has traditionally been treated through conservative measures like physical therapy and anti-inflammatory medications. However, the integration of innovative technologies into the medical field is now opening up new avenues for diagnosis and treatment, transforming the global Impingement Syndrome market. In January 2023, Orthofix Medical Inc. and SeaSpine Holdings Corporation have successfully completed their previously announced merger of equals, following approval from the stockholders of both companies during their respective special meetings. A remarkable 99% of SeaSpine common shares and 98% of Orthofix common shares were voted in favor of the merger.
The advent of high-resolution imaging technologies like magnetic resonance imaging (MRI) and ultrasound has greatly improved the accuracy of diagnosing Impingement Syndrome. These tools allow healthcare professionals to visualize the shoulder joint and surrounding tissues in detail, enabling more precise diagnosis and treatment planning. Three-dimensional modeling techniques have emerged as powerful tools in the diagnosis of Impingement Syndrome. By creating detailed 3D models of the shoulder joint, doctors can better understand the structural issues contributing to impingement and plan interventions accordingly.
Key Market Players
Bioventus LLC
Orthofix Medical Inc.
Breg, Inc.
ConMed Corporation
Ossur hf.
Arthrex, Inc.
Globus Medical, Inc.
NuVasive, Inc.
Stryker Corporation
Medtronic plc
Report Scope:
In this report, the Global Impingement Syndrome Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Impingement Syndrome Market, By Type of Musculoskeletal Disorder:
Osteoarthritis
Rheumatoid Arthritis
Osteoporosis
Back and Neck Pain
Shoulder Impingement Syndrome
Knee Pain and Disorders
Impingement Syndrome Market, By Diagnosis and Imaging Techniques:
X-ray
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT) Scan
Ultrasound
Arthroscopy
Others
Impingement Syndrome Market, By Treatment Modalities:
Medications
Surgical Interventions
Impingement Syndrome Market, By End User:
Hospitals & Clinics
Ambulatory Care Centers
Others
Impingement Syndrome Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Impingement Syndrome Market.
Available Customizations:
Global Impingement Syndrome market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Impingement Syndrome Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type of Musculoskeletal Disorder (Osteoarthritis, Rheumatoid Arthritis, Osteoporosis, Back and Neck Pain, Shoulder Impingement Syndrome, Knee Pain and Disorders, Hip Pain and Disorders, Trauma and Fracture, Sports Injuries, Others)
5.2.2. By Diagnosis and Imaging Techniques (X-ray, Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Ultrasound, Arthroscopy, Others)
5.2.3. By Treatment Modalities (Medications and Surgical Interventions)
5.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Impingement Syndrome Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type of Musculoskeletal Disorder
6.2.2. By Diagnosis and Imaging Techniques
6.2.3. By Treatment Modalities
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Impingement Syndrome Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type of Musculoskeletal Disorder
6.3.1.2.2. By Diagnosis and Imaging Techniques
6.3.1.2.3. By Treatment Modalities
6.3.1.2.4. By End User
6.3.2. Canada Impingement Syndrome Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type of Musculoskeletal Disorder
6.3.2.2.2. By Diagnosis and Imaging Techniques
6.3.2.2.3. By Treatment Modalities
6.3.2.2.4. By End User
6.3.3. Mexico Impingement Syndrome Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type of Musculoskeletal Disorder
6.3.3.2.2. By Diagnosis and Imaging Techniques
6.3.3.2.3. By Treatment Modalities
6.3.3.2.4. By End User
7. Europe Impingement Syndrome Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type of Musculoskeletal Disorder
7.2.2. By Diagnosis and Imaging Techniques
7.2.3. By Treatment Modalities
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Impingement Syndrome Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type of Musculoskeletal Disorder
7.3.1.2.2. By Diagnosis and Imaging Techniques
7.3.1.2.3. By Treatment Modalities
7.3.1.2.4. By End User
7.3.2. United Kingdom Impingement Syndrome Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type of Musculoskeletal Disorder
7.3.2.2.2. By Diagnosis and Imaging Techniques
7.3.2.2.3. By Treatment Modalities
7.3.2.2.4. By End User
7.3.3. Italy Impingement Syndrome Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type of Musculoskeletal Disorder
7.3.3.2.2. By Diagnosis and Imaging Techniques
7.3.3.2.3. By Treatment Modalities
7.3.3.2.4. By End User
7.3.4. France Impingement Syndrome Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type of Musculoskeletal Disorder
7.3.4.2.2. By Diagnosis and Imaging Techniques
7.3.4.2.3. By Treatment Modalities
7.3.4.2.4. By End User
7.3.5. Spain Impingement Syndrome Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type of Musculoskeletal Disorder
7.3.5.2.2. By Diagnosis and Imaging Techniques
7.3.5.2.3. By Treatment Modalities
7.3.5.2.4. By End User
8. Asia-Pacific Impingement Syndrome Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type of Musculoskeletal Disorder
8.2.2. By Diagnosis and Imaging Techniques
8.2.3. By Treatment Modalities
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Impingement Syndrome Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type of Musculoskeletal Disorder
8.3.1.2.2. By Diagnosis and Imaging Techniques
8.3.1.2.3. By Treatment Modalities
8.3.1.2.4. By End User
8.3.2. India Impingement Syndrome Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type of Musculoskeletal Disorder
8.3.2.2.2. By Diagnosis and Imaging Techniques
8.3.2.2.3. By Treatment Modalities
8.3.2.2.4. By End User
8.3.3. Japan Impingement Syndrome Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type of Musculoskeletal Disorder
8.3.3.2.2. By Diagnosis and Imaging Techniques
8.3.3.2.3. By Treatment Modalities
8.3.3.2.4. By End User
8.3.4. South Korea Impingement Syndrome Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type of Musculoskeletal Disorder
8.3.4.2.2. By Diagnosis and Imaging Techniques
8.3.4.2.3. By Treatment Modalities
8.3.4.2.4. By End User
8.3.5. Australia Impingement Syndrome Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type of Musculoskeletal Disorder
8.3.5.2.2. By Diagnosis and Imaging Techniques
8.3.5.2.3. By Treatment Modalities
8.3.5.2.4. By End User
9. South America Impingement Syndrome Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type of Musculoskeletal Disorder
9.2.2. By Diagnosis and Imaging Techniques
9.2.3. By Treatment Modalities
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Impingement Syndrome Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type of Musculoskeletal Disorder
9.3.1.2.2. By Diagnosis and Imaging Techniques
9.3.1.2.3. By Treatment Modalities
9.3.1.2.4. By End User
9.3.2. Argentina Impingement Syndrome Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type of Musculoskeletal Disorder
9.3.2.2.2. By Diagnosis and Imaging Techniques
9.3.2.2.3. By Treatment Modalities
9.3.2.2.4. By End User
9.3.3. Colombia Impingement Syndrome Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type of Musculoskeletal Disorder
9.3.3.2.2. By Diagnosis and Imaging Techniques
9.3.3.2.3. By Treatment Modalities
9.3.3.2.4. By End User
10. Middle East and Africa Impingement Syndrome Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type of Musculoskeletal Disorder
10.2.2. By Diagnosis and Imaging Techniques
10.2.3. By Treatment Modalities
10.2.4. By End User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Impingement Syndrome Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type of Musculoskeletal Disorder
10.3.1.2.2. By Diagnosis and Imaging Techniques
10.3.1.2.3. By Treatment Modalities
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Impingement Syndrome Market Outlook
